The Hartford Insurance Group, Inc. (HIG): what the price requires

At today's price, The Hartford Insurance Group, Inc. (HIG) is priced for 14.4% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/HIG

Headline

FieldValue
TickerHIG
CompanyThe Hartford Insurance Group, Inc.
Current price$140.73/sh
CompositionBusiness Insurance 56% / Personal Insurance 14% / P&C Other Operations 0% / Employee Benefits 25% / Hartford Funds 4%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed14.4%
Return on equity now20.5%
ROE gap-6.1pp
Price-to-book2.08x

Solve inputs: computed at a 9% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~2.1pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.85σ
cohort percentile (of 80 peers)55
sustained it ~10 years at this level62%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.90x3justifies
Earnings0.61x2justifies
Relative0.28x3justifies
Growth1.11x1expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.4%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$235.560.60xyesTBVPS $60.66 × 3.88x (ROE (TTM) 21.5% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$170.720.82xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.2x / 11.0x / 12.8x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$156.890.90xyesBV/sh $67.48, ROE (TTM) 21.5%, ke 9.3%
Two-Stage Excess ReturnAsset$237.570.59xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$127.331.11xyesRev $28.8B, growth 7% (input: historical growth; tapered), Terminal P/S: 1.1x / 1.4x / 1.6x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$497.350.28xyesEPS $14.21, growth 35% (input: historical EPS growth), PEG=0.28 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$146.890.96xyes√(22.5 × EPS $14.21 × BVPS $67.48) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$458.510.31xyesEPS $14.21 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$532.880.26xyesEPS $14.21 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$153.620.92xyesEPS $14.21 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-4.6%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The Hartford's moat is diversification done well: it is not a single-line insurer riding one product, but a balanced franchise spanning commercial property and casualty, personal lines, employee benefits, and asset management. The filing describes revenue streams that include "premiums earned for insurance coverage provided to insureds," management fees on mutual fund and ETF assets, and net investment income, which is a wider base than most insurers carry. Business Insurance, the largest segment, is the engine: it grew written premium 6% in the first quarter of 2026 with a combined ratio of 94.8% and an underlying combined ratio near 89%, evidence of disciplined underwriting across commercial lines, including in the excess and surplus market where pricing has been strong.

The returns the franchise produces are genuinely high. Core earnings were $866 million, or $3.09 per diluted share, in the quarter, and the trailing core return on equity reached about 20.3%. For a property-and-casualty insurer, a sustained return on equity in the high teens to low twenties is excellent, and it reflects both underwriting profit and a larger investment portfolio earning more as rates have risen. The Employee Benefits segment adds a group life and disability book that diversifies away from catastrophe-exposed property risk, smoothing the overall result.

Capital allocation closes the loop. The Hartford returned $617 million to shareholders in the quarter through dividends and buybacks, and the share count has fallen about 4.6% a year. A profitable, multi-line insurer earning a high return on equity and steadily retiring shares is compounding book value per share in a way the static methods recognize: every family of valuation method supports the current price rather than calling it stretched. The bull case is a well-run, diversified franchise with disciplined underwriting and consistent capital return.

Bear Case

The structural risk in any property-and-casualty insurer is that the balance sheet is built on estimates that can prove wrong, and the high recent returns are a function of a benign part of the cycle. The Hartford's reserves for long-tail liabilities depend on assumptions about claims that have not fully emerged; the filing notes that for long-term disability there is a period "generally ranging from two to twelve months" where claim information for a given year is "not yet credible enough" to fully assess. Reserve adequacy is the quiet risk in insurance: a company can look highly profitable for years and then take a charge when older accident years develop worse than booked. A trailing return on equity near 20% is a peak-cycle figure, not a guarantee, which is precisely why the price assumes it fades toward 13.6% rather than holding.

The valuation already reflects the good times. At about 1.9 times book the stock sits in the upper half of its peer group's price-to-book, which means the market is crediting the strong underwriting and high returns rather than discounting them. That leaves little room for the cycle to turn. Commercial-lines pricing has been firm, but property and casualty is cyclical: rate adequacy attracts capital, capital intensifies competition, and competition erodes the very combined ratios that justify the premium multiple. If Business Insurance pricing softens or catastrophe losses spike, both the earnings and the book value that supports the multiple come under pressure at once.

The quarter itself showed the limits. Core earnings of $3.09 per share, while up from a year earlier, fell short of the roughly $3.39 consensus, and the Business Insurance combined ratio of 94.8% leaves only a modest underwriting margin before catastrophe and reserve surprises. The Employee Benefits and personal lines segments add diversification but also their own exposures, from mortality and morbidity trends to auto and home loss costs. A premium-priced insurer earning peak returns, with reserve risk embedded in the balance sheet and a cyclical core, is a thesis with more downside than its steady appearance suggests.

Valuation

An insurer is worth the return it earns on its capital, so the lens is price against book value. At about $128 (June 27, 2026) The Hartford trades near 1.9 times book and the price assumes a sustained return on equity of roughly 13.6%. The company has recently been earning closer to 20.5% on a trailing core basis, so the price is not demanding improvement; it assumes the strong returns moderate from their current peak. That is a reasonable bet for a P&C insurer, which is why the priced-in assumption reads as within range.

Every family of valuation method supports the price. The asset-value and earnings-power methods, which read the insurer off its book and current returns, land at or above today's level; the relative-multiple and growth methods reach it too. None calls the stock expensive. The peer-multiple read anchors on a sector P/E near 11 times, and The Hartford's diversified, profitable franchise is a quality name within that cohort. The honest framing is that the price is supported on multiple independent measures, with the upper-half price-to-book reflecting the market paying for the high returns and the diversification rather than stretching for them. The wide gap between the bear and bull valuation scenarios reflects the genuine cyclicality of insurance earnings rather than any disagreement about the current quality.

Solvency for an insurer is read on capital adequacy and reserve strength, not corporate leverage; net-debt and coverage math do not apply to a float-funded balance sheet. The relevant facts are the disciplined combined ratios, the trailing return on equity around 20%, and the consistent capital return: $617 million to shareholders in the quarter and a share count falling about 4.6% a year. What a buyer underwrites at this price is a high-quality, diversified insurer earning strong returns the market expects to moderate, with reserve adequacy and the property-and-casualty cycle as the risks the steady multiple does not fully price.

Catalysts

The Hartford opened 2026 with strong underwriting results. Core earnings were $866 million, or $3.09 per diluted share, up from a year earlier, with trailing core earnings return on equity improving to about 20.3%. The Business Insurance segment, the company's largest, grew written premium 6% and posted a combined ratio of 94.8%, with an underlying combined ratio near 89%, reflecting disciplined execution across commercial lines. The cause behind the result was firm commercial pricing combined with strong investment income, partly offset by the modest miss against the roughly $3.39 consensus EPS estimate.

Capital return continued at pace, with the company returning $617 million to shareholders through dividends and buybacks in the quarter, consistent with a multi-year reduction in share count. That capital return is the steady mechanism converting the high return on equity into per-share value.

The forward catalysts to watch are the trajectory of Business Insurance pricing and the combined ratio across the property-and-casualty cycle, the level of catastrophe losses through the year, and any reserve development on long-tail liability lines. The performance of the Employee Benefits and personal lines segments, along with the investment portfolio's net investment income as rates evolve, will round out the picture at the next print.

Peer Cohorts (Per Segment, With Filing Citations)

Business Insurance (reported)

Personal Insurance (reported)

P&C Other Operations (reported)

Employee Benefits (reported)

Hartford Funds (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

HIG Q1 2026 results, April 2026 · HIG FY2025 10-K

View the full interactive HIG report on boothcheck